Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical differences between benign and malignant pheochromocytomas.

B Glodny1, G Winde, R Herwig

  • 1Institute of Pharmaceutical Biology and Phytochemistry, Westfalische Wilhelms-Universität Münster, Germany.

Endocrine Journal
|July 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marginalized Identities, Healthcare Discrimination, and Parental Stress about COVID-19.

Journal of marriage and the family·2025
Same author

Utility of Routine Preoperative <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy. Reply.

The Journal of urology·2021
Same author

The application of a new laminitis scoring method to model the rate and pattern of improvement from equine endocrinopathic laminitis in a clinical setting.

BMC veterinary research·2021
Same author

Densely Populated Water Droplets in Heavy-Oil Seeps.

Applied and environmental microbiology·2020
Same author

The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies.

BMC veterinary research·2019
Same author

Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?

European radiology·2018
Same journal

Corticotropin-releasing factor as a regulator of adrenal glucocorticoid synthesis and brain function: a scientific journey of a neuroendocrine physician.

Endocrine journal·2026
Same journal

Teprotumumab-associated persistent unilateral hearing loss in dysthyroid optic neuropathy: a case report with review of the literature.

Endocrine journal·2026
Same journal

Early diagnosis of capivasertib-associated severe hyperglycemia with diabetic ketosis diagnosed in routine clinical practice: a case report with review of literature.

Endocrine journal·2026
Same journal

Clinical characterization of Japanese children with Cushing's disease.

Endocrine journal·2026
Same journal

Associations of stress hormones, autonomic function, and endothelial function in patients with diabetes.

Endocrine journal·2026
Same journal

Inter- and intratumoral heterogeneity of aldosterone-producing adenomas: recent advances and clinical implications.

Endocrine journal·2026
See all related articles

Differentiating malignant from benign pheochromocytomas is crucial due to differing prognoses. Shorter patient histories and extraadrenal tumors suggest malignancy, while typical symptoms like hypertension and headaches often indicate benign pheochromocytomas.

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Pathology

Background:

  • Pheochromocytomas are adrenal tumors with varying prognoses.
  • Malignant pheochromocytomas have a less favorable outcome compared to benign types.
  • Early detection and differentiation are key for effective surgical management.

Purpose of the Study:

  • To distinguish between typical clinical signs and symptoms of malignant versus benign pheochromocytomas.
  • To identify indicators that suggest a higher likelihood of malignancy.
  • To improve diagnostic accuracy for pheochromocytoma subtypes.

Main Methods:

  • Retrospective analysis of 133 patient records from 1967 to 1998.
  • Comparison of tumor characteristics (size, location, duration of symptoms) between benign and malignant cases.

Related Experiment Videos

  • Statistical analysis of clinical manifestations (hypertension, headaches, sweating, etc.) in both groups.

    • Main Results:

    • Malignant pheochromocytomas were larger (9.4 cm vs. 5.9 cm) and had shorter histories (7.4 months vs. 47.4 months).
    • Extrathyroidal tumors were more common in malignant cases (24.1% vs. 7.7%).
    • Typical symptoms like hypertension and headaches were more frequent in benign cases, while abdominal pain and back pain were more common in malignant ones.

    Conclusions:

    • Unusually short patient histories and extraadrenal tumor location are suspicious for pheochromocytoma malignancy.
    • Classic clinical signs and symptoms are more indicative of benign pheochromocytomas.
    • Accurate differentiation aids in tailoring treatment and improving patient outcomes.